The burden of cancer mortality falls disproportionately on cancer patients belonging to ethnic minority groups.
In the U.S., African American, Hispanic, and American Indian cancer patients are diagnosed at a more advanced stage and receive less appropriate treatment, resulting in poorer outcomes and higher mortality, than white cancer patients.
The authors hypothesized that cancer control strategies based on earlier detection and more effective treatment may be most effective in increasing survival in groups with more advanced disease at diagnosis, less appropriate treatment, and lower survival.
Data collected by the New Mexico Tumor Registry, a member organization of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, afforded the authors an opportunity to investigate this hypothesis by studying trends in cancer survival for American Indians, Hispanics, and non-Hispanic whites.
The authors examined temporal trends and ethnic disparities in survival for in situ and invasive incident cancer cases at 25 sites diagnosed from 1969 through 1994 in New Mexico residents and in American Indians residing in Arizona.
The distribution of stage became more favorable and the percentage of patients receiving appropriate treatment increased for all three ethnic groups during the study period. (...)
Mots-clés Pascal : Tumeur maligne, Hémopathie maligne, Survie, Pronostic, Epidémiologie, Amérindien, Latinoaméricain, Caucasoïde, Ethnie, Nouveau Mexique, Etats Unis, Amérique du Nord, Amérique, Arizona, Homme
Mots-clés Pascal anglais : Malignant tumor, Malignant hemopathy, Survival, Prognosis, Epidemiology, Amerindian, Latinamerican, Caucasoid, Ethnic group, New Mexico, United States, North America, America, Arizona, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0236033
Code Inist : 002B04B. Création : 11/09/1998.